Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00923377 · ClinicalTrials.gov registry record
Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 3
- Enrollment target
NCT00923377 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 3 participants.
The verdict
NCT00923377 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
Background: * Research suggests that breast cancers may arise from a population of stem cells in the normal mammary gland that produce clones of cancer cells. * Researchers are now trying to determine what events may initiate the formation of cancer cells. Objectives: * To look for and describe breast stem cells from normal breast tissue from women who do not have breast cancer. * To compare the breast stem cells between women at increased risk for breast cancer and women at average risk for breast cancer. * To show a relationship between the number and type of breast stem cells with the density (appearance) of the mammogram (breast x-ray). * To make cell cultures (grow cells under controlled conditions) from the breast stem cells. Eligibility: -Women 18 years of age and older who are at average or increased risk for breast cancer. Design: Participants complete a health history questionnaire, family history questionnaire and risk assessment questionnaire. * Participants have a mammogram and breast biopsy (surgical removal of a sample of breast tissue). * Women who can become pregnant have a urine pregnancy test....
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-03-23 |
| Est. Completion | 2010-05-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00923377
The ClinicalTrials.gov registry entry for NCT00923377 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00923377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00923377 about?
NCT00923377 is a clinical study titled "Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer". Background: * Research suggests that breast cancers may arise from a population of stem cells in the normal mammary gland that produce clones of cancer cells. * Researchers are now trying to determine what events may initiate the formation of cancer cells. Objectives: * To look for and describe b...
What is the current status of trial NCT00923377?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2007-03-23. Estimated completion is 2010-05-11.
Who is sponsoring clinical trial NCT00923377?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.